一种增长合策略,以改善大肠杆菌中类生物生产的稳定性
Jing Chong Tan1, Qitiao Hu1, Nigel S Scrutton2
1Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
Microbial cell factories
|October 16, 2024
概括
这项研究介绍了一种增长合策略,通过将细胞生长与化物生产联系起来,来增强工业生物制造. 这种方法稳定了生物生产,并提高了工程化大肠杆菌的成本竞争力.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 合成生物学 合成生物学
背景情况:
- 工业生物制造面临成本挑战,原因是全细胞生物催化剂的生产异质性.
- 细胞生产率的遗传变异导致进化有利于低/非生产者,损害生物过程性能和商业可行性.
- 提高跨细胞代的生物生产稳定性对于工业应用至关重要.
研究的目的:
- 设计和实施一种增长合策略,用于Escherichia coli中的类生物生产.
- 为了创建一种微生物底盘,它依赖于异质甲酸途径,用于所有类合成.
- 假设必需的内源性类生物合成将强制执行最低生产率,提高目标化合物生产.
主要方法:
- 通过敲除原生1-deoxy-D-xylulose-5-phosphate降低异构酶 (dxr) 基因来进行工程化大肠杆菌.
- 引入了一种异质的甲酸盐途径,用于必需和甲的合成.
- 挑战的工程菌株 (Δdxr) 具有连续的基于等离子体的林纳醇生物生产.
主要成果:
- 与父母菌株相比,Ddxr菌株在最初几天表现出更好的生产力.
- 生产力持续长达12天,即使在营养和氧气限制的情况下.
- 该Ddxr菌株显示出不同的进化轨迹,避免了有害的突变和等离子体损失,表明成功的生长合.
结论:
- 展示了增长合策略的概念证明,以提高类生物制造的性能和稳定性.
- 该战略具有广泛的适用性,并作为一种"防故障"机制,防止生产率下降.
- 这种方法具有很大的潜力,可以推进工业生物生产的努力.
关键词:
持续的文化 持续的文化进化 进化 进化 进化 进化 进化 进化基因稳定性 基因稳定性工业生物制造工业生物制造代谢工程是代谢工程.现型稳定性 现型稳定性质粒损失 质粒损失人口异质性 人口异质性坚固性 坚固性应变工程是一种应变工程.更多相关视频
相关概念视频
Coordination of Gene Expression Processes in Bacteria
The DNA replication, transcription, and translation processes are intricately coupled in bacteria, allowing efficient gene expression and rapid protein synthesis. While this physical and functional coordination is advantageous, it introduces challenges that bacteria overcome through specific regulatory mechanisms.Coupling of Replication, Transcription, and TranslationThe coupling of replication, transcription, and translation is a hallmark of bacterial gene expression. As the replisome unwinds...
Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


